Advertisement
News
Subscribe to MDT Magazine News

Grants fund projects that will tackle ‘Grand Challenges'

December 17, 2010 2:33 pm | by Arizona State University | Comments

ASU engineering faculty will lead projects to address some of the world's most critical problems with support from the Grand Challenges Research Seed Funding programread more

TOPICS:

Hospitals Challenge MDMA Study That Criticizes Funding of GPOs

December 17, 2010 12:32 pm | by U.S. Food & Drug Administration | Comments

The nation’s largest hospitals are challenging a device industry report that claims group purchasing organizations (GPO) increase the cost of healthcare.

FDA Told to Review New Data Relating to Dental Amalgam

December 17, 2010 12:32 pm | by U.S. Food & Drug Administration | Comments

The FDA should review new data to determine if dental amalgam should be reclassified, its Dental Advisory Panel recommends.

Advertisement

UnitedHealth Group trims 3Q lobbying to $550,000

December 17, 2010 11:45 am | by The Associated Press | Comments

Managed care company UnitedHealth Group Inc. slashed its third-quarter lobbying spending by 46 percent compared with the same quarter last year, when the health care reform overhaul debate heated up in Congress.The Minnetonka, Minn., insurer spent $550,000 in the three months that ended Sept....

Express Scripts expansion could mean 150 jobs

December 17, 2010 11:45 am | by The Associated Press | Comments

The pharmacy benefit manager firm Express Scripts Inc. is adding a fourth building at its headquarters site in north St. Louis County, a move expected to create up to 150 new jobs.Gov. Jay Nixon was on hand Friday to join in the announcement. The 227,000-square-foot building will open in about...

Express Scripts expansion may mean 150 jobs in Mo.

December 17, 2010 11:45 am | by The Associated Press | Comments

The pharmacy benefit manager firm Express Scripts Inc. is adding a fourth building at its headquarters site in north St. Louis County, a move expected to create up to 150 new jobs.Gov. Jay Nixon was on hand Friday to join in the announcement. The 227,000-square-foot building will open in about...

<i>Blog: </i>No fear means new scientific possibilities

December 17, 2010 11:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Lynette Cornell blogs: A middle-aged woman with no concept of fear has helped scientists learn more about how the brain not only perceives the fear of others but responds to fear-inducing stimuli itself. The discovery holds great promise for many potential applications in managing fear,...

WellPoint spent $1.1 M on 3Q federal lobbying

December 17, 2010 10:45 am | by The Associated Press | Comments

Health insurer WellPoint Inc. spent $1.1 million lobbying the federal government in the third quarter, as it focused on several issues tied to the health care overhaul Congress passed in March.The Indianapolis insurer lobbied on Medicare Advantage and implementation of the overhaul, which aims...

Advertisement

GE Healthcare finishes first part of Clarient bid

December 17, 2010 10:45 am | by The Associated Press | Comments

GE Healthcare said Friday that it completed the first part of its offering for diagnostic services company Clarient Inc.The General Electric Co. unit agreed in October to buy Clarient for $570 million in cash, or about $5 per share. GE Healthcare said about 84 percent of Clarient's common and...

Katz joins NeuroMetrix board

December 17, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | Comments

NeuroMetrix Inc., a Waltham-based developer of medical devices and therapies to treat neurological and spinal conditions, has appointed Nancy Katz to its board of directors.

FDA Workshop - Assuring the Safety and Effectiveness of Seizure, Cognitive Function, and TBI/Sports Concussion Diagnostic Devices, June 2-3, 2011

December 17, 2010 10:33 am | by U.S. Food & Drug Administration | Comments

Attendees will discuss approaches and endpoints for clinical studies for these devices and how the results should be conveyed to the users so that the devices may be used effectively.

RXi plans IND for anti-scarring treatment

December 17, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | Comments

RXi Pharmaceuticals Corp. of Worcester is preparing to bring its first RNAi product into development, with the filing of an investigational new drug (IND) application for its therapeutic candidate in reducing surgical scarring.

Accuray Establishes Medical Affairs Function

December 17, 2010 9:33 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Dec. 17, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the company has established a Medical Affairs function to accelerate CyberKnife data collection, utilization and referral patterns and to provide...

TOPICS:

Boston researchers test treatment for autism link

December 17, 2010 9:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Children's Hospital Boston scientists have initiated a three-year clinical trial to test a potential treatment for Rett Syndrome, known to cause autism in girls.

TOPICS:

Anzemet (dolasetron mesylate): Drug Safety Communication - Reports of Abnormal Heart Rhythms

December 17, 2010 8:34 am | by U.S. Food & Drug Administration | Comments

Injection form of Anzemet (dolasetron mesylate) should no longer be used to prevent nausea and vomiting associated with cancer chemotherapy in pediatric and adult patients.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading